Full Breakdown
Ancient Bacteria in Romanian Ice Cave Exhibit Antibiotic Resistance
2/22/2026, 10:03:39 PM
Discovery of Psychrobacter SC65A.3
Researchers have identified a bacterial strain, Psychrobacter SC65A.3, preserved for approximately 5,000 years in the Scarisoara Ice Cave in Romania. This strain exhibits resistance to ten modern antibiotics, including rifampicin, vancomycin, and ciprofloxacin, which are commonly used to treat serious bacterial infections such as tuberculosis and urinary tract infections. The study, published in the journal *Frontiers in Microbiology*, highlights the implications of thawing ancient microbes as global temperatures rise.
Research Methodology
The bacterial strain was isolated from a 25-meter (82-foot) ice core drilled from the Great Hall section of the cave, which contains a record of 13,000 years of frozen material. The researchers sequenced the genome of SC65A.3 to identify genes associated with cold survival and antimicrobial resistance. They tested the strain against 28 antibiotics from ten different classes, revealing its resistance profile and the presence of over 100 resistance-related genes.
Implications of Findings
The findings raise significant concerns regarding the potential risks associated with the melting of ice and the release of ancient microbes. Dr. Cristina Purcarea, a senior scientist at the Institute of Biology Bucharest, noted that while most ancient microbes are harmless, some could carry antibiotic resistance genes that may transfer to modern bacteria, exacerbating the global challenge of antibiotic resistance. The World Health Organization has warned that antibiotic resistance is a major threat to global health, contributing to nearly 5 million deaths annually.
Potential Benefits
Despite the risks, the study also suggests potential benefits. The Psychrobacter SC65A.3 strain has shown the ability to inhibit the growth of several antibiotic-resistant "superbugs" and possesses enzymatic activities that could be harnessed for biotechnological applications. The researchers identified 11 genes in the strain that may have the potential to kill or inhibit other bacteria, fungi, and viruses, indicating a promising avenue for developing new antibiotics.
Criticism & Opposition
Some experts caution against the uncontrolled release of ancient microbes, emphasizing the need for careful handling and safety measures in laboratory settings. The dual nature of these ancient bacteria—as both a potential threat and a source of new biotechnological innovations—highlights the complexity of addressing antibiotic resistance.
Official Statements & Responses
Dr. Purcarea stated, “Studying microbes such as Psychrobacter SC65A.3 reveals how antibiotic resistance evolved naturally in the environment, long before modern antibiotics were ever used.” She also emphasized the importance of monitoring melting ice regions to anticipate risks and expand scientific knowledge about these ancient life forms.
What's Next
As climate change continues to impact global temperatures, ongoing research will be crucial in understanding the implications of releasing ancient microbes into modern ecosystems. Scientists advocate for controlled studies to explore both the risks and the potential benefits of these long-dormant microorganisms.
Verbatim Quotes
- “The 10 antibiotics we found resistance to are widely used in oral and injectable therapies used to treat a range of serious bacterial infections in clinical practice,” — Dr. Cristina Purcarea, Senior Scientist, Institute of Biology Bucharest
- “If melting ice releases these microbes, these genes could spread to modern bacteria, adding to the global challenge of antibiotic resistance,” — Dr. Cristina Purcarea, Senior Scientist, Institute of Biology Bucharest
- “These ancient bacteria are essential for science and medicine, but careful handling and safety measures in the lab are essential to mitigate the risk of uncontrolled spread,” — Dr. Cristina Purcarea, Senior Scientist, Institute of Biology Bucharest
